Merck & Co (MRK)

$105.92 0.00 (0.00%)

19:00 EDT MRK Stock Quote Delayed 30 Minutes

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

By Muslim Farooque, InvestorPlace Contributor Mar 21, 2023

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

7 Defensive Stocks to Buy During This Chaotic Spell

3 Large-Cap Biotech Stocks to Hold for the Long Haul

The 7 Most Undervalued Blue-Chip Stocks to Buy in February 2023

Volume:

Previous Close -

Market Cap 268.12B

PE Ratio 26.41

EPS 4.01

Volume (Avg. Vol.) 8

Day's Range -

52-Week Range $81.64 - $115.49

Dividend & Yield $2.60 (2.45%)

MRK Stock Predictions, Articles, and Merck & Co News

From InvestorPlace
From the Web

The 7 Most Undervalued Dow Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.

7 Healthcare Stocks That Will Be Big Winners in 2023

By Alex Sirois Jan 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

7 Hot Healthcare Stocks to Watch in 2023

By Joel Baglole, InvestorPlace Contributor Jan 11, 2023

Strong earnings and robust dividend payments make healthcare stocks attractive during times of uncertainty and volatility.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor Jan 6, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

3 Top Stocks of 2022 That Will Shine Again in 2023

By Will Ashworth, InvestorPlace Contributor Jan 4, 2023

The S&P 500 had its worst year since 2008. Of the 143 stocks that gained this past year, these three top stocks of 2022 could do it again.

7 Perfect Presents to Gift Your 2023 Stock Portfolio

By Alex Sirois Dec 21, 2022

These stocks to buy have significant potential and serious catalysts as we move into the new year.

7 Top-Rated Large-Cap Stocks to Buy and Hold

By Louis Navellier and the InvestorPlace Research Staff Dec 16, 2022

Large-cap stocks are always great to have in a portfolio. These companies are the biggest – and some of the best-known – stocks in the stock market. That makes finding the best large-cap stocks a worthy exercise.

3 Dow Stocks to Take Seriously in 2023

By Will Ashworth, InvestorPlace Contributor Nov 29, 2022

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

3 Biotech Stocks Smart Investors Should Be Buying Up Now

By Chris MacDonald, InvestorPlace Contributor Nov 24, 2022

These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.

The 25 Best Stocks to Buy for Retirement

By Omor Ibne Ehsan Nov 19, 2022

It's an ideal time to look for the best retirement stocks to buy as many stocks trade at massive discounts while the market signals a bottom.

7 Value Stocks to Buy Before They Pop Off

By Larry Ramer, InvestorPlace Contributor Nov 15, 2022

Data shows that it's time for investors to abandon the largest Big Tech names and find attractive value stocks to buy.

7 No-Brainer Retirement Stocks to Buy for 2023 and Beyond

By Muslim Farooque, InvestorPlace Contributor Nov 8, 2022

These no-brainer retirement stocks have proven to be amazingly consistent in delivering incredible returns for investors over time.

7 Stocks to Sell Before They Give Back This Year’s Gain

By Chris Markoch, InvestorPlace Contributor Oct 24, 2022

Some of the big winners from this year could find themselves giving back some hard-earned gains. Here are seven stocks to sell before they do

Why Is Moderna (MRNA) Stock Up 10% Today?

By David Moadel, InvestorPlace Contributor Oct 12, 2022

The medical community is witnessing a potential watershed moment in vaccine development. And MRNA stock traders are in a buying mood.

What Is Going on With Ginkgo Bioworks (DNA) Stock Today?

By David Moadel, InvestorPlace Contributor Oct 11, 2022

Ginkgo's planned collab with a pharma giant should spark a rally in DNA stock - but then, sometimes logic doesn't prevail on Wall Street.

Merck (MRK) Stock Jumps 4% on Positive Trial Data

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2022

Merck took a big gamble in buying a therapeutic as part of an acquisition deal and it appears to have paid off, sending MRK stock soaring.

7 Blue-Chip Sleeper Stocks to Buy Before Wall Street Wakes Up

By Tezcan Gecgil, InvestorPlace Contributor Sep 28, 2022

Here're seven blue-chip sleeper stocks with wide moats

7 Dow Sleeper Stocks to Buy Before Wall Street Wakes Up

By Josh Enomoto, InvestorPlace Contributor Sep 26, 2022

While these market ideas may be boring as can be, Dow sleeper stocks may command a premium for their defensive tendencies.

Why Is Evaxion Biotech (EVAX) Stock Up Today?

By Chris MacDonald, InvestorPlace Contributor Sep 21, 2022

Today's news that Evaxion Biotech has enrolled its first patient in a key clinical trial has sent shares of EVAX stock soaring today.

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

By Will Ashworth, InvestorPlace Contributor Sep 20, 2022

Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.

Merck & Co (MRK)

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

7 Defensive Stocks to Buy During This Chaotic Spell

3 Large-Cap Biotech Stocks to Hold for the Long Haul

The 7 Most Undervalued Blue-Chip Stocks to Buy in February 2023

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Merck & Co (MRK)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRK Stock Predictions, Articles, and Merck & Co News

Subscriber Sign in